DBV Technologies S.A. buy phonebroker
Start price
23.10.17
/
50%
€49.22
Target price
30.10.17
€55.00
Performance (%)
-17.09%
End price
30.10.17
€40.81
Summary
This prediction ended on 30.10.17 with a price of €40.81. The price of DBV Technologies S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.09%. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| DBV Technologies S.A. | -5.426% | -5.426% | 123.560% | 12.295% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by phonebroker for this prediction
In the thread DBV Technologies S.A. diskutieren
peanut allergy treatment fails to meet main goal in late-stage study
DBV Technologies peanut allergy treatment fails to meet main goal in late-stage study
Ein Tipp an sharewise:
Die Einschätzungen "anderer Mitglieder" sind Schrott, was sich mit meiner Empfehlung zu beweisen erscheint.
(Vom Mitglied beendet)